Advocating for Rituximab As First-Line Treatment for NMOSD-AQP4 Patients in France: Cost and Efficacy Considerations.
Romain Deschamps,Caroline Papeix,Xavier Ayrignac,Bertrand Bourre,Jonathan Ciron,Mikael Cohen,Nicolas Collongues,Kumaran Deiva,Françoise Durand Dubief,David-Axel Laplaud,Elisabeth Maillart,Laure Michel,Julie Pique,Aurélie Ruet,Eric Thouvenot,Hélène Zéphir,Romain Marignier,Bertrand Audoin Revue Neurologique（2024）
AI 理解论文
溯源树
样例
